SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Iovance Reports Lifileucel Response Rate in Soft-Tissue Sarcoma Pilot Study

Iovance reported a response rate for Lifileucel in a pilot study in soft-tissue sarcomas.

IOVA

Related stories